Health Catalyst, INC Schedule 13G passive stakes

A significant stakeholder group, including Stoney Lonesome HF LP and Coghill Capital Management LLC, has updated its beneficial ownership filing for Health Catalyst, Inc., reporting a combined 9.6% stake.

Impax Asset Management Group plc and its subsidiary Impax Asset Management LLC have reported beneficial ownership of 5.4% of Health Catalyst, Inc. common stock as of June 30, 2026.

Clint D. Coghill and associated entities have filed an amended Schedule 13G reporting an 8.6% beneficial ownership stake in Health Catalyst, Inc.

The Vanguard Group has filed an amended Schedule 13G, indicating 0% beneficial ownership in Health Catalyst Inc. following an internal realignment.

Whetstone Capital Advisors and David Atterbury have disclosed a 5.3% beneficial ownership stake in Health Catalyst, Inc. as of December 31, 2025.

Clint D. Coghill and affiliated entities have reported a combined beneficial ownership of 5.5% in Health Catalyst, Inc. common stock.

First Light Asset Management and its managing member, Mathew P. Arens, reported a combined beneficial ownership of 19.75% in Health Catalyst, Inc. common stock as of September 30, 2025.

Whetstone Capital Advisors and David Atterbury have reported a 5.4% beneficial ownership stake in Health Catalyst, Inc. as of June 30, 2025.

First Light Asset Management, LLC and its managing member, Mathew P. Arens, have disclosed a combined beneficial ownership of 17.18% of Health Catalyst, Inc.'s common stock in an updated SEC filing.

The Vanguard Group has filed an Amendment No. 7 to its Schedule 13G, reporting a 5.88% beneficial ownership stake in Health Catalyst Inc. as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.3% beneficial ownership stake in Health Catalyst, Inc.'s common stock as of March 31, 2025.

First Light Asset Management, LLC and its managing member, Mathew P. Arens, have disclosed a passive beneficial ownership of 11.75% in Health Catalyst, Inc. common stock.